A technical report in Pediatrics, published on 1 October, set out the evidence behind the American Academy of Pediatrics' 2026 urinary tract infection guideline. The authors ran five systematic reviews covering 60 studies on antibiotic duration, route, continuous prophylaxis in vesicoureteral reflux and in bladder and bowel dysfunction, and the timing of evaluation.
The certainty of evidence was low to very low throughout. Within that, courses of seven days or fewer did not appear to raise recurrence and were likely to cause fewer adverse effects. Oral antibiotics may be as effective as parenteral or parenteral-then-oral treatment, avoiding the harms of admission. Continuous prophylaxis in children with reflux or bladder and bowel dysfunction may not lower breakthrough infection or renal scarring, but may increase antibiotic-resistant infection. Evaluation within 72 hours of symptom onset was associated with less renal scarring.
Together these point towards a simpler pathway: see febrile children promptly, treat most with a short oral course, and reserve prophylaxis for selected cases. In India, where resistance in urinary pathogens is high, the warning that prophylaxis may breed resistant infection is particularly relevant. Indian Academy of Pediatrics guidance should be checked locally; this review does not change it.
- See a febrile child with suspected UTI within 72 hours of symptom onset; later evaluation was linked to more scarring.
- Consider an oral antibiotic for children well enough to take it, rather than routine admission for intravenous therapy.
- Consider a course of seven days or fewer for uncomplicated UTI in children without known anatomical anomalies.
- Do not start continuous prophylaxis routinely in reflux or bladder and bowel dysfunction; weigh the resistance risk.
- Treat bladder and bowel dysfunction itself — constipation and voiding habits — rather than relying on antibiotics.
Why it matters
It reverses long-standing habits of long courses, intravenous starts and routine prophylaxis that add harm and resistance.
Don't overread it
The certainty of evidence was low to very low; these are the most likely directions, not firm conclusions.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free